UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000025527 |
|---|---|
| Receipt number | R000028116 |
| Scientific Title | A prospective study of Endoscopic retrograde cholangiography for pancreatobiliary diseases |
| Date of disclosure of the study information | 2017/01/04 |
| Last modified on | 2022/08/03 12:04:30 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A prospective study of Endoscopic retrograde cholangiography for pancreatobiliary diseases
Acronym
A prospective study of ERCP for pancreatobiliary diseases
Scientific Title
A prospective study of Endoscopic retrograde cholangiography for pancreatobiliary diseases
Scientific Title:Acronym
A prospective study of ERCP for pancreatobiliary diseases
Region
| Japan |
Condition
Condition
Pancreatobiliary diseases
Classification by specialty
| Hepato-biliary-pancreatic medicine |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the feasibility and safety of ERCP
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
A technical and clinical success rate
Key secondary outcomes
Complications, Long term follow up
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
The case that planned ERCP or EUS intervention
Key exclusion criteria
The case that we cannnot get agreement
Target sample size
5000
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kazuo Hara |
Organization
Aichi Cancer Center Hospital
Division name
Gastroenterology
Zip code
Address
1-1, kanokoden, chikusa-ku,Nagoya
TEL
052-762-611
khara@aichi-cc.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kazuo Hara |
Organization
Aichi Cancer Center Hospital
Division name
Gastroenterology
Zip code
Address
1-1, kanokoden, chikusa-ku,Nagoya
TEL
052-762-611
Homepage URL
khara@aichi-cc.jp
Sponsor or person
Institute
Aichi Cancer Center Hospital
Institute
Department
Personal name
Funding Source
Organization
Aichi Cancer Center Hospital
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 01 | Month | 04 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2016 | Year | 05 | Month | 23 | Day |
Date of IRB
| 2016 | Year | 05 | Month | 23 | Day |
Anticipated trial start date
| 2017 | Year | 01 | Month | 04 | Day |
Last follow-up date
| 2027 | Year | 01 | Month | 03 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
The purpose of this study is that we register the case that planned ERCP and we investigate it forward and examine clinical results.
Management information
Registered date
| 2017 | Year | 01 | Month | 04 | Day |
Last modified on
| 2022 | Year | 08 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028116
